J&J targets Devine right to win
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
After spending most of the decade tackling production and recall issues in the US, Johnson & Johnson’s (J&J’s) global OTC business is now ready to fully reassert itself in the global marketplace as Katie Devine, global president of the firm’s OTC franchise, tells Matt Stewart.